ArticleBMC pulmonary medicine2019

Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience.

Kodai Kawamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.